Copyright Reports & Markets. All rights reserved.

Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral
      • 1.4.3 Parenteral (Subcutaneous Injection)
    • 1.5 Market by Application
      • 1.5.1 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2014-2025)
      • 1.5.2 Drug Store
      • 1.5.3 Independent Pharmacies
      • 1.5.4 Hospital Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Opioid-Induced Constipation (OIC) Treatment Market Size
    • 2.2 Opioid-Induced Constipation (OIC) Treatment Growth Trends by Regions
      • 2.2.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Manufacturers
      • 3.1.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served
    • 3.3 Key Players Opioid-Induced Constipation (OIC) Treatment Product/Solution/Service
    • 3.4 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2014-2019)
    • 4.2 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
    • 5.2 Opioid-Induced Constipation (OIC) Treatment Key Players in United States
    • 5.3 United States Opioid-Induced Constipation (OIC) Treatment Market Size by Type
    • 5.4 United States Opioid-Induced Constipation (OIC) Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
    • 6.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Europe
    • 6.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type
    • 6.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application

    7 China

    • 7.1 China Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
    • 7.2 Opioid-Induced Constipation (OIC) Treatment Key Players in China
    • 7.3 China Opioid-Induced Constipation (OIC) Treatment Market Size by Type
    • 7.4 China Opioid-Induced Constipation (OIC) Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
    • 8.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Japan
    • 8.3 Japan Opioid-Induced Constipation (OIC) Treatment Market Size by Type
    • 8.4 Japan Opioid-Induced Constipation (OIC) Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
    • 9.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size by Type
    • 9.4 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size by Application

    10 India

    • 10.1 India Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
    • 10.2 Opioid-Induced Constipation (OIC) Treatment Key Players in India
    • 10.3 India Opioid-Induced Constipation (OIC) Treatment Market Size by Type
    • 10.4 India Opioid-Induced Constipation (OIC) Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
    • 11.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Central & South America
    • 11.3 Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
    • 11.4 Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 GlaxoSmithKline
      • 12.1.1 GlaxoSmithKline Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.1.5 GlaxoSmithKline Recent Development
    • 12.2 AstraZeneca
      • 12.2.1 AstraZeneca Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.2.5 AstraZeneca Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 S.L.A. Pharma
      • 12.4.1 S.L.A. Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.4.5 S.L.A. Pharma Recent Development
    • 12.5 AIKO Biotechnology
      • 12.5.1 AIKO Biotechnology Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.5.5 AIKO Biotechnology Recent Development
    • 12.6 Cubist Pharmaceuticals
      • 12.6.1 Cubist Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.6.5 Cubist Pharmaceuticals Recent Development
    • 12.7 Salix Pharmaceuticals
      • 12.7.1 Salix Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.7.5 Salix Pharmaceuticals Recent Development
    • 12.8 Takeda Pharmaceutical
      • 12.8.1 Takeda Pharmaceutical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Opioid-Induced Constipation (OIC) Treatment Introduction
      • 12.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2014-2019)
      • 12.8.5 Takeda Pharmaceutical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Opioid-Induced Constipation (OIC) Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Opioid-Induced Constipation (OIC) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opioid-Induced Constipation (OIC) Treatment development in United States, Europe and China.

      The key players covered in this study
      GlaxoSmithKline
      AstraZeneca
      Pfizer
      S.L.A. Pharma
      AIKO Biotechnology
      Cubist Pharmaceuticals
      Salix Pharmaceuticals
      Takeda Pharmaceutical

      Market segment by Type, the product can be split into
      Oral
      Parenteral (Subcutaneous Injection)

      Market segment by Application, split into
      Drug Store
      Independent Pharmacies
      Hospital Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Opioid-Induced Constipation (OIC) Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Opioid-Induced Constipation (OIC) Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Opioid-Induced Constipation (OIC) Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now